Intellia Therapeutics Inc buy melinda
Start price
08.03.18
/
50%
€28.31
Target price
10.09.18
€68.55
Performance (%)
-13.22%
End price
10.09.18
€24.57
Summary
This prediction ended on 10.09.18 with a price of €24.57. The prediction for Intellia Therapeutics Inc disappointed with a performance of -13.22%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | 11.848% | 11.848% | 94.719% | -58.082% |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % | 49,53 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % | 96,25 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % | 64,69 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % | 67,57 % |
According to melinda what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 13/03 | 20.50 Präsentation
mehr
$ NTLA mit einem Outperform bei JMP Initiiert & $ 76 PT
(Laufzeit überschritten)
Stopped prediction by melinda for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€18.68
21.05.20
21.05.20
€30.00
04.11.21
04.11.21
531.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year


